Abstract
The growing burden of valvular heart disease in Western countries represents a challenge for the daily clinical practice, especially in the light of the ever-increasing number of therapeutic options. The Euro Heart Survey showed that, among elderly subjects with severe, symptomatic valve dysfunction, surgery is denied for 33% of patients with aortic stenosis and for 50% of patients with mitral regurgitation. Current management (from diagnosis to follow-up) is often fragmented in multiple-sometimes unnecessary-steps. Such a "patchy" approach may translate into a suboptimal management, especially in the geriatric population. New healthcare models exist that can coordinate care, reduce fragmentation, limit costs and, ultimately, improve outcomes: the clinical pathways.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 126-133 |
| Numero di pagine | 8 |
| Rivista | Critical Pathways in Cardiology |
| Volume | 20 |
| Numero di pubblicazione | 3 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2021 |
All Science Journal Classification (ASJC) codes
- Cardiologia e Medicina Cardiovascolare
Keywords
- Critical pathway
- Heart valve clinic
- Personalized medicine
- Valvular heart disease
Fingerprint
Entra nei temi di ricerca di 'Heart valve critical pathway and heart valve clinic: novel benchmarks for modern management of valvular heart disease'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver